📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $795.3822
- Sector: Healthcare – Biotechnology
💡 The Growth Thesis
Buy Consensus: Regeneron Pharmaceuticals, Inc. Analysts project a 3.0% potential upside. Currently trading at a Forward P/E of 17.415808.